Logo

Cellway Ventures Changes Name to Acrongenomics

Mar 05, 2004

NEW YORK, March 5 (GenomeWeb News) - Cellway Ventures has changed its name to Acrongenomics, the company said today.

 

The company, based in Calgary, Canada, said it changed its name "to more accurately reflect its emerging business." Its symbol on the Over The Counter Bulletin Board will change from CWYV to AGNM.

 

Earlier this year, the company said it is negotiating to acquire a European pharmaceutical company and patents and rights to a predictive molecular diagnostic test for metastatic cancer from European scientists.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.